Rebif 44 MCG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYEK8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,385
Award facts
- Contract value 100% obligated
- $13,385.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,385.40 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Rebif 44 micrograms per 0.5 milliliter syringes. This firm fixed-price contract, which represents a non-competitive award, is scheduled for completion by August 12, 2025, with performance taking place at the contractor's Conshohocken facility. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical procurement system, particularly for military and veteran healthcare needs. Rebif, an interferon beta-1a treatment used for multiple sclerosis management, represents the type of specialized pharmaceutical commodity that AmerisourceBergen regularly supplies through its DLA contract vehicle to support Defense Health Agency operations and other federal healthcare systems. The non-set-aside designation and firm fixed pricing structure are consistent with the competitive, open-market procurement approach that characterizes AmerisourceBergen's federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FYEK8?
SPE2DB25FYEK8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FYEK8 worth?
The government has obligated $13,385 on SPE2DB25FYEK8.
Is contract SPE2DB25FYEK8 an order under another contract?
Yes. SPE2DB25FYEK8 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYEK8 competed?
The extent of competition for SPE2DB25FYEK8 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award